![Safety and efficacy of reduced-dose pentamidine as second-line treatment for HIV-related pneumocystis pneumonia - ScienceDirect Safety and efficacy of reduced-dose pentamidine as second-line treatment for HIV-related pneumocystis pneumonia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1341321X20302063-gr1.jpg)
Safety and efficacy of reduced-dose pentamidine as second-line treatment for HIV-related pneumocystis pneumonia - ScienceDirect
![Table 2 from ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. | Semantic Scholar Table 2 from ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/427eabd3d175a37bc2f82ab35ff1da1a9918b7fc/3-Table2-1.png)
Table 2 from ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. | Semantic Scholar
![Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years | Critical Care | Full Text Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years | Critical Care | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13054-018-2221-8/MediaObjects/13054_2018_2221_Fig1_HTML.png)
Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years | Critical Care | Full Text
![JoF | Free Full-Text | Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection JoF | Free Full-Text | Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection](https://www.mdpi.com/jof/jof-09-00812/article_deploy/html/images/jof-09-00812-g001.png)
JoF | Free Full-Text | Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection
![Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients | European Respiratory Society Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients | European Respiratory Society](https://erj.ersjournals.com/content/erj/39/4/971/F2.large.jpg)
Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients | European Respiratory Society
![Non‐HIV‐infected patients with Pneumocystis pneumonia in the intensive care unit: A bicentric, retrospective study focused on predictive factors of in‐hospital mortality - Wang - 2022 - The Clinical Respiratory Journal - Wiley Non‐HIV‐infected patients with Pneumocystis pneumonia in the intensive care unit: A bicentric, retrospective study focused on predictive factors of in‐hospital mortality - Wang - 2022 - The Clinical Respiratory Journal - Wiley](https://onlinelibrary.wiley.com/cms/asset/19918447-3a20-4675-966f-199cfbe8ce88/crj13463-fig-0001-m.jpg)
Non‐HIV‐infected patients with Pneumocystis pneumonia in the intensive care unit: A bicentric, retrospective study focused on predictive factors of in‐hospital mortality - Wang - 2022 - The Clinical Respiratory Journal - Wiley
![Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infection - The Lancet Infectious Diseases Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infection - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/19154135-bef5-4eae-9304-299b96c8f66d/gr1_lrg.jpg)